Montreal, Quebec--(Newsfile Corp. - September 9, 2025) - Manganese X Energy Corp. (MN:CA) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) ("Manganese X" or the "Company") is pleased to announce it is ...
This chapter discusses the foundational basis for the current body armor testing methodologies as practiced by military and law enforcement agencies. In the 1970s developments in fiber technology and ...
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research sessionAcross the COAST 1, ...
AcelRx Pharmaceuticals has begun the final phase of its three studies on a new patient-controlled analgesia system, ARX-01, the Sufentanil NanoTab PCA System, according to PharmaBiz.com. This phase is ...
During Phases I and II of the study, the committee was requested to consider the use of statistics to permit a more scientific determination of sample sizes to be used in body armor testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results